Direktorat Registrasi ObatValid

SANDOSTATIN LAR

Claim this product
BPOM Number
DKI2281602044B1
Approved
1 January 2026
Expiry
31 December 2030
Form
SERBUK INJEKSI + PELARUT

About This Registration

SANDOSTATIN LAR is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKI2281602044B1. Its current registration status is Valid, with the licence valid until 31 December 2030. The product is registered to NOVARTIS INDONESIA - INDONESIA. BPOM first approved this registration in December 2025. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application
newaero
Packaging
DUS, 1 VIAL @ 625 MG + 1 PRE FILLED SYRINGE @ 2 ML PELARUT + 1 VIAL ADAPTER + 1 SAFETY INJECTION NEEDLE
Department
Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

Ingredients (1)

OCTREOTIDE ACETATE

Market Intelligence

Owner Portfolio
NOVARTIS INDONESIA - INDONESIA holds 142 BPOM registrations
Manufacturer Scale
NOVARTIS INDONESIA - INDONESIA produces 142 registered products
Registration Age
Registered for 8 months

FDA Cross-Reference

via openFDA
Generic Name
OCTREOTIDE ACETATE
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
INTRAVENOUS

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product

More products from NOVARTIS INDONESIA - INDONESIA

TASIGNA

-DKI2621002001A1
Valid
Approved: May 24, 2026KAPSUL
View product →

EXFORGE 5/80

-DKI2601700617A1
Valid
Approved: Apr 16, 2026TABLET SALUT SELAPUT
View product →

EXFORGE 10/160

-DKI2601700617C1
Valid
Approved: Apr 16, 2026TABLET SALUT SELAPUT
View product →

SANDOSTATIN LAR

-DKI2281602044B1
Valid
Approved: Dec 31, 2025SERBUK INJEKSI + PELARUT
View product →

TYKERB

-DKI2057000117A1
Valid
Approved: Dec 31, 2025TABLET SALUT SELAPUT
View product →

Products in the same class

TEVEN 10

-DKL2625905910A1
Valid
Approved: Mar 31, 2026TABLET
TRIMAN
View product →

SILDENAFIL CITRATE

-GKL2502509217A1
Valid
Approved: Dec 31, 2025TABLET SALUT SELAPUT
DIPA PHARMALAB INTERSAINS - INDONESIA
View product →

NEO UNI OBH

-DBL2526303837A1
Valid
Approved: Dec 31, 2025SIRUP
UNIVERSAL PHARMACEUTICAL INDUSTRIES
View product →

CEFIXIME TRIHYDRATE

-GKL2558402338A1
Valid
Approved: Dec 26, 2025SUSPENSI KERING
EMDI MELIA PHARMA - INDONESIA
View product →

LYNPARZA

-DKI2159602717B1
Valid
Approved: Dec 23, 2025TABLET SALUT SELAPUT
ASTRAZENECA INDONESIA - INDONESIA
View product →
1